medigraphic.com

2019, Number 2

Next >>

Cuba y Salud 2019; 14 (2)

Cardiovascular complications and their risk factors in adult patients with Chronic Kidney Disease

Souchay DL, Sotolongo LD, Álvarez GY, Castillo DMC

Language: Spanish
References: 32
Page: 3-10
PDF size: 834.41 Kb.


ABSTRACT

Objective: to describe the cardiovascular complications and their main determining factors in adult patients with chronic kidney disease in the office 10, Polyclinic “Adrián Sansaricq” of Artemis, from October 2016 to April 2018.
Materials and Methods: a descriptive, longitudinal prospective study was conducted. The universe was composed of 856 people. The sample was represented by 214 patients. The variables used were the classification of Chronic Kidney Disease, basic cause, age, sex, cardiovascular risk factors, complications, comorbidities and causes of death. The information was obtained from the individual medical records.
Results: Chronic Kidney Disease predominated in women and older adults between 60-69 years. The G3a stage prevailed in the classification of said disease. The main basic causes were hypertensive and diabetic nephropathy, followed by urinary obstruction. There was a high exposure to cardiovascular risk factors with a higher percentage of smokers and the presence of phosphocalcic disorders, mostly in older adults. Heart Failure, arrhythmias and anemia predominated as associated comorbidities. 2.8% of the cases investigated, predominantly, due to cardiovascular causes and malignancies.
Conclusions: Chronic Renal Disease was diagnosed in a high percentage of people, mainly associated with Arterial Hypertension, diabetes Mellitus and the elderly.


REFERENCES

  1. Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) study equations for estimating GFR levels above 60 ml/min/1.73 m2. Am J Kidney Dis 2013; 56:486-95.

  2. Lou Arnal LM, Campos Gutiérrez B, Boned Juliani B, Turón Calzado JM, Gimeno Orna JA. Estimación del filtrado glomerular en atención primaria: prevalencia de enfermedad renal crónica y repercusión sobre la derivación a nefrología. Nefrología 2008 [citado Feb 2015]; 28(3):329-32. Disponible en: http://www.revistanefrologia.com/revistas/P1-E28/P1-E28-S289-A477.pdf.

  3. Piepoli MF, Hoes AW, Agewall S1, Albus C2, Brotons C3, Catapano AL, et al. European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016 Aug 1; 37(29):2315-2381.

  4. Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F,Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM; Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014 May 24; 383(9931):1831-43.

  5. Mitchell C. OPS OMS | La OPS/OMS y la Sociedad Latinoamericana de Nefrología llaman a prevenir la enfermedad renal y a mejorar el acceso al tratamiento. Pan American Health Organization / World Health Organization. 2015. p. 1–5.

  6. Gonzalez-Bedat M, Rosa-Diez G, Pecoits-Filho R, Ferreiro A, García-García G, Cusumano A, et al. Burden of disease: prevalence and incidence of ESRD in Latin America. Clin Nephrol [Internet]. 2015; 83 (7 Suppl 1):3-6. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/ 25725232.

  7. Afsar B, Turkmen K, Covic A, Kanbay M. An update on coronary artery disease and chronic kidney disease. Int J Nephrol2014; 2014: 767424.

  8. Pérez Oliva J L,Herrera Valdés R,Almaguer López R. Situación de la enfermedad renal crónica en Cuba.En :Anuario Cuba Nefro-Red ;2014.

  9. Brotons C, Royo-Bordonada MA, A ́lvarez-Sala L, et al: Adaptación de la Guía Europea de Prevención Cardiovascular. Nefrología 2014; 24: 312-328.

  10. Muntner P, Judd SE, Gao L, Gutierrez OM, Rizk DV, McClellan W, et al. Cardiovascular risk factors in CKD associate with both ESRD and mortality. J Am Soc Nephrol 2013; 24(7):1159-65.

  11. Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, et al. Risk factors for increased left ventricular hypertrophy in patients with chronic kidneydisease. Clin Exp Nephrol 2013; 17(5):730-42.

  12. Arroyo D, Betriu A, Martinez-Alonso M, Vidal T, Valdivielso JM, et al. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study. BMC Nephrol 2014; 15: 168. doi:10.1186/1471-2369-15-168.

  13. Lorenzo V, Pedrosa MI, Santana B, García Z, Barroso M. Análisis de costes y perfil sociocultural del enfermo renal. Impacto de la modalidad de tratamiento. Nefrología 2014; 34(4):458-68.

  14. Solini A, Penno G, Bonora E, Fondelli C, Orsi E, Trevisan R, et al. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. J Am Geriatr Soc 2013; 61:1253-61.

  15. Alcázar R, Egocheaga M, Orte L et al. Documento de consenso SEN-semFYC sobre la enfermedad renal crónica. Nefrologia 2013; 28: 273-282.

  16. Martínez-Castelao A, Górriz JL, Bover J, et al: “Documento de Consenso para la detección y manejo de la enfermedad renal crónica. NEFROLOGIA 2014; 34(2): 243-262.

  17. El Husseini N, Kaskar O, Goldstein LB. Chronic kidney disease and stroke. Adv Chronic Kidney Dis2014; 21(6):500-8.

  18. Ricardo AC, Lash JP, Fischer MJ, Lora CM, Budoff M, Keane MG, et al. Cardiovascular disease among hispanics and non-hispanics in the chronic renal insufficiency cohort (CRIC) study. Clin J Am Soc Neph 2011;6(9): 2121-31.

  19. Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study.AmJ Kidney Dis 2010; 55(1):21-30.

  20. Medellín J. Carrillo G. Soporte social percibido y calidad de vida de personas con enfermedad renal crónica sometidas a trasplante renal. Revista Avances en Enfermería. 2014; 32 (2): 206 – 216.

  21. Departamento de Estadísticas. Dirección Provincial de Salud Pública. Comportamiento de Enfermedades Crónicas no Transmisibles. Artemisa; 2016.

  22. Sánchez-Celaya del Pozo M, Tranche Iparraguirre S. Documento de consenso sobre la enfermedad renal crónica. S.E.N-semFYC. Atención Primaria. 2014; 46:453–4.

  23. Salvador González B, Rodríguez Pascual M, Ruipérez Guijarro L, Ferré González A, CunilleraPuertolas O, Rodríguez Latre LM. Enfermedad renal crónica en atención primaria: prevalencia y factores de riesgo asociados. Atención Primaria. 2015; 47:236–45.

  24. Francis ER, Kuo CC, Bernabe-Ortiz A, Nessel L, Gilman RH, Checkley W, et al. Burden of chronic kidney disease in resource-limited settings from Peru: a population-based study. BMC Nephrol. 2015; 16:114.

  25. Heras,M.J. Fernández-Reyes,R. Sánchez,M.T. Guerrero,A. Molina,M.A. Rodríguez. Ancianos con enfermedad renal crónica: ¿qué ocurre a los cinco años de seguimiento? Nefrología, 32 (2012), pp. 300-305.

  26. Subisa A, Odriozola M,Ruiz P, et al. Riesgo Cardiovascular en la Enfermedad Renal Crónica.RevUrugCardiol 2016; 31:206-218.

  27. Informe de Diálisis y Trasplante 2012. Registros Autonómicos-de Enfermos Renales-ONT. Registro Español de Enfermos Renales. Disponible en: http://www.senefro.org/modules/webstructure/files/reer_datos_2012_sen_bilbao_2013.pdf.

  28. Almy Roosveiky Mérida Alvarado. Tesis para optar por el título de Médica y Cirujana. Riesgo Cardiovascular en pacientes con Enfermedad Renal Crónica, estudio de 74 pacientes mayores de 18 años de enero 2015-julio 2015.Hospital Nacional de Huehuetenango. Guatemala.

  29. Brotons C, Royo-Bordonada MA, Álvarez-Sala L, et al: Adaptación de la Guía Europea de Prevención Cardiovascular. Nefrología 2014; 24: 312-328.

  30. Papademetriou V, Lovato L, Doumas M, NylenE, Mottl A, Cohen RM, et al. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney Int 2015; 87(3):649-59.

  31. Borst MH, Vervloet MG, ter Wee PM, Navis G. Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF- 23-klotho in chronic kidney disease. J Am Soc Nephrol 2011;22(9):1603-9.

  32. Arroyo D, Betriu A, Martinez-Alonso M, Vidal T, Valdivielso JM, et al. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study. BMC Nephrol 2014; 15: 168. doi: 10.1186/1471-2369-15-168.




2020     |     www.medigraphic.com